modelMelatonin_Merchant2013_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:melatonin
ATC code:N05CH01
model:one compartment, IV dosing (PK_1C)
source:Merchant NM et al. 2013
population:preterm infants
measured compound:melatonin
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
median half-life15.82ht1/2z
median maximum plasma concentration203.3pg ml(-1)Cmax
clearance0.045l h(-1)CL
volume of distribution1.098lV

About melatonin

Melatonin, a hormone made by the pineal gland, is used as a hypnotic for sleep problems such as jet lag, and in the EU also for sleep disorders in autism. It is widely used, with authorised products in the European Union, and is also available as a supplement and approved for veterinary use.

Summary written by glm-5.3-flash from Wikidata Q180912 and the WHO ATC classification and the EMA medicines list; not checked by a person.

Identity, molar mass and metabolites: Melatonin.

References

  1. Merchant NM et al. (2013). Pharmacokinetics of melatonin in preterm infants. British journal of clinical pharmacology 76(5):725–733. DOI:10.1111/bcp.12092 PUBMED:23432339

Parameters

TypeNameDefaultDescription
RealCl_ref1.25e-08Cl [m3/s]
RealVd_ref0.001098Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Merchant_2013: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate